Inventor
MARKUS LOEFFLER
Inventor
DE
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C07KPeptides16%
C12NMicroorganisms or enzymes16%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
B01DSeparation3%
B29CShaping or joining of plastics3%
B29KIndexing scheme associated with subclasses b29b, b29c or b29d, relating to moulding materials or to materials for moulds, reinforcements, fillers or preformed parts, e.g. inserts3%
B29LIndexing scheme associated with subclass b29c, relating to particular articles3%
D01DMechanical methods or apparatus in the manufacture of artificial filaments, threads, fibres, bristles or ribbons3%
PatentTitleYear
12,145,108Spinneret202411,559,550Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers202311,560,405Peptides and combination thereof for use in the immunotherapy against cancers202311,542,303Peptides and combination thereof for use in the immunotherapy against cancers202311,427,614Peptides and combination thereof for use in the immunotherapy against cancers202211,135,246Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (5)· patent assignee history
2021–2024Based in DE· patent location history
2024Patents assigned to GAMBRO LUNDIA AB (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMATICS BIOTECHNOLOGIES GMBH | 5 | 2021–2023 |
| GAMBRO LUNDIA AB | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 6 | 2021–2024 |